TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
UCB Pharma AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
150,868
|
163,053
|
186,563 |
Financial expenses |
2,148
|
1,279
|
871 |
Earnings before taxes |
3,932
|
4,906
|
5,867 |
Total assets |
98,632
|
89,177
|
100,804 |
Current assets |
98,514
|
89,078
|
100,734 |
Current liabilities |
76,678
|
69,128
|
79,684 |
Equity capital |
21,954
|
20,049
|
21,119 |
- share capital |
328
|
350
|
369 |
Employees (average) | 9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
22.3%
|
22.5%
|
21.0% |
Turnover per employee | 18,117 | ||
Profit as a percentage of turnover |
2.6%
|
3.0%
|
3.1% |
Return on assets (ROA) |
6.2%
|
6.9%
|
6.7% |
Current ratio |
128.5%
|
128.9%
|
126.4% |
Return on equity (ROE) |
17.9%
|
24.5%
|
27.8% |
Change turnover |
-2,165
|
-13,711
|
-5,000 |
Change turnover % |
-1%
|
-8%
|
-3% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.